Current and future strategies for the treatment of malignant brain tumors

MG Castro, R Cowen, IK Williamson, A David… - Pharmacology & …, 2003 - Elsevier
Glioblastoma (GB) is the most common subtype of primary brain tumor in adults. These
tumors are highly invasive, very aggressive, and often infiltrate critical neurological areas …

The application of genetically engineered herpes simplex viruses to the treatment of experimental brain tumors.

SS Andreansky, B He, GY Gillespie… - Proceedings of the …, 1996 - National Acad Sciences
Due to lack of effective therapy, primary brain tumors are the focus of intense investigation of
novel experimental approaches that use vectors and recombinant viruses. Therapeutic …

Interleukin-17 inhibits tumor cell growth by means of a T-cell–dependent mechanism

F Benchetrit, A Ciree, V Vives, G Warnier… - Blood, The Journal …, 2002 - ashpublications.org
Abstract Interleukin 17 (IL-17) is a proinflammatory cytokine produced by activated CD4+
memory T cells. We previously showed that IL-17 increased the growth rate of human …

Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukins

S Andreansky, B He, J Van Cott, J McGhee, JM Markert… - Gene therapy, 1998 - nature.com
This report describes a test of the hypothesis that the oncolytic effect of genetically
engineered, replication competent herpes simplex viruses (HSV) depends both on cell …

A pathogenic role of Th2 cells and their cytokine products on the pulmonary metastasis of murine B16 melanoma

M Kobayashi, H Kobayashi, RB Pollard… - The Journal of …, 1998 - journals.aai.org
The role of Th2 cells and the cytokines produced by these cells on experimental pulmonary
metastasis of B16 melanoma was investigated in a murine model implanted with high …

Glioma immunology and immunotherapy

IF Parney, C Hao, KC Petruk - Neurosurgery, 2000 - journals.lww.com
OBJECTIVE: Despite advances in conventional therapy, the prognosis for most glioma
patients remains dismal. This has prompted an intensive search for effective treatment …

Targeted delivery of plasmid DNA complexed with galactosylated poly (L-lysine)

M Hashida, S Takemura, M Nishikawa… - Journal of controlled …, 1998 - Elsevier
Galactose was introduced to poly (l-lysine)(PLL) with an average molecular weight of 13,000
to develop a hepatocyte-specific carrier for gene drugs. The pharmacokinetic characteristics …

The antibody‐based targeted delivery of interleukin‐4 and 12 to the tumor neovasculature eradicates tumors in three mouse models of cancer

T Hemmerle, D Neri - International journal of cancer, 2014 - Wiley Online Library
Preclinical studies with recombinant murine interleukin 4 (IL4) in models of cancer have
shown potent tumor growth inhibition. However, systemic administration of human IL4 to …

Gene therapy for malignant glioma

H Okura, CA Smith, JT Rutka - Molecular and cellular therapies, 2014 - Springer
Glioblastoma multiforme (GBM) is the most frequent and devastating primary brain tumor in
adults. Despite current treatment modalities, such as surgical resection followed by …

Gene expression and antitumor effects following direct interferon (IFN)-γ gene transfer with naked plasmid DNA and DC-chol liposome complexes in mice

T Nomura, K Yasuda, T Yamada, S Okamoto… - Gene therapy, 1999 - nature.com
Gene expression was assessed in three types of mouse solid tumors after direct injection of
naked plasmid DNA encoding the luciferase gene (pCMV-Luc) and its DC-chol liposome …